| Examiner | Number of Cases | 3YGR |
|---|---|---|
| Examiner Boeckelman | 231 | 24% |
| Examiner Cain | 14 | 0% |
| Examiner Chen | 234 | 43% |
| Examiner Desai (SPE) | 356 | 80% |
| Examiner Fiebig | 399 | 65% |
| Examiner Hoffman | 425 | 54% |
| Examiner Kosar | 383 | 79% |
| Examiner Meller | 646 | 69% |
| Examiner Mi | 688 | 81% |
| Examiner Moehlman | 12 | 0% |
| Examiner Moreau | 0 | 0% |
| Examiner Spaine | 0 | 0% |
| Art Unit 1655 | 3388 | 66% |
| Number | Class Description |
|---|---|
| 424 | Drug, bio-affecting and body treating compositions |
| 435 | Chemistry: molecular biology and microbiology |
| 514 | Drug, bio-affecting and body treating compositions |
| 530 | Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof |
| 426 | Food or edible material: processes, compositions, and products |
| 131 | Tobacco |
| 128 | Surgery |
| 536 | Organic compounds -- part of the class 532-570 series |
| 549 | Organic compounds -- part of the class 532-570 series |
| 434 | Education and demonstration |
Art Unit 1655's grant rate is higher than that of Group 1650 and lower than that of the USPTO.
Below is the grant rate timeline for Art Unit 1655, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.